Autoimmunity and vascular involvement in systemic sclerosis (SSc).
about
Cardiovascular disease in systemic sclerosis--an emerging association?MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblastsPaclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor HGlobal chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.Coagulation and autoimmunity in scleroderma interstitial lung disease.IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathwayProtein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitroRole of endothelin in fibrosis and anti-fibrotic potential of bosentan.Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factorsRetrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.At the heart of tissue: endothelin system and end-organ damage.Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis.An overview of environmental risk factors in systemic sclerosis.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.The role of platelets in the pathogenesis of systemic sclerosis.Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma.Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.Organ involvement in Argentinian systemic sclerosis patients with "late" pattern as compared to patients with "early/active" pattern by nailfold capillaroscopy.Early identification of vascular damage in patients with systemic sclerosis.MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis.
P2860
Q21195262-37B910E9-C67F-4B3C-981D-DB01DCD91ACFQ24802883-00E0C448-1BAE-432D-8C9C-CC745D251530Q24811751-77096DE5-7416-486E-9AB6-9798B3173A6AQ33588440-785E5867-114B-458C-BB38-E5DFC336E767Q33668640-3F2EC29A-5EF0-4349-9F13-FE42A1E0A445Q33826259-8ABAAAB5-ADEC-422A-8913-CD2A4ED5AFE9Q34770486-5661FE6F-FDD6-4545-9E86-FE35B878E2C4Q35078513-27BAFD0C-0F9D-4268-83BF-7D8BFFC44D1EQ35100214-DC0A153B-644E-4017-91DE-2E207A6384FBQ36132271-F6EF2F26-7C48-48D9-96A1-84879ADB8626Q36757042-6286513E-0D71-47AF-A48B-09B6E4A18E40Q37515708-8F0A7C9F-3C8B-4E12-9174-6328D5D958EAQ37780253-FB7E11C0-B4D7-4721-9FCD-09A19363F508Q38603115-97B581EF-DD13-4673-BEC6-44D303FB6AB4Q38648592-521EC8F3-365C-4DB4-BA82-97E85531CCEDQ38663003-5E25CE9B-384E-473F-806E-F8820E217465Q40134411-B85BE3C3-D3F1-4E2E-8037-9B6588F43AC7Q42203442-38FA8F6F-5733-4E94-9BCE-FF95ED54B1D5Q42870658-5C489CCE-A6E2-4E71-B16B-AADBB5F646DCQ44062256-6FF0DF72-F411-4733-A06D-B3331856996AQ46012346-634C47D9-3F02-445F-A938-06B7943AD709Q50683587-B948CE76-E456-4AB1-B79A-7380BF42A006Q52659036-CADB79C1-E392-4339-938B-9F4BD72DF825
P2860
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@ast
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@en
type
label
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@ast
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@en
prefLabel
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@ast
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@en
P2860
P1433
P1476
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
@en
P2093
P2860
P304
P356
10.3109/08916939908994064
P577
1999-01-01T00:00:00Z